Vontobel Holding Ltd. Denali Therapeutics Inc. Transaction History

Vontobel Holding Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $521,652 - $850,292	-17,988 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $169,848 - $219,419	3,988 Added 28.49%	17,988 $810,000
Q3 2021 Oct 29, 2021	SELL	$48.48 - $78.23 $12,313 - $19,870	-254 Reduced 1.78%	14,000 $706,000
Q2 2021 Aug 06, 2021	BUY	$50.3 - $78.44 $12,776 - $19,923	254 Added 1.81%	14,254 $1.12 Million
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $516,460 - $1.31 Million	14,000 New	14,000 $1.08 Million

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.